There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

Affordable and Safe Prescription Drug Importation Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.

Actions Overview (1)

Date Actions Overview
01/10/2019Introduced in House

All Actions (3)

Date All Actions
01/25/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
01/10/2019Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
01/10/2019Introduced in House
Action By: House of Representatives

Cosponsors (26)

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce01/10/2019 Referred to
House Energy and Commerce Subcommittee on Health01/25/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Latest Summary (1)

There is one summary for H.R.447. View summaries

Shown Here:
Introduced in House (01/10/2019)

Affordable and Safe Prescription Drug Importation Act

This bill addresses the importation of drugs from Canada and other foreign countries.

The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries.

The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.